Eliana Clark, EVP, Chief Technical Officer at Intellia Therapeutics, Inc. (NTLA), sold 8,909 shares at $29.46 ($263K) on 2024-01-03, disclosed to the SEC on 2024-01-05.
Open-market sale of $263k NTLA by EVP, Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.46 | 4,301 | $127K | 48.2% |
| 2 | $29.46 | 4,301 | $127K | 48.2% |
| 3 | $30.12 | 307 | $9K | 3.5% |
| Total | $29.48 avg | 8,909 | $263K | 100% |
| Filing → |
| NTLA | SELL | 2025-07-03 | $10K | — | Filing → |
| NTLA | SELL | 2025-03-04 | $6K | — | Filing → |
| NTLA | SELL | 2025-01-06 | $187K | — | Filing → |